Rasburicase (Elitek): a novel agent for tumor lysis syndrome

Những quyển sách tương tự

• Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase
  Bằng: Alakel, Nael, et al.
  Được phát hành: (2017)
• Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout
  Bằng: Cammalleri, Lisa, et al.
  Được phát hành: (2007)
• Reduced administration of rasburicase for tumor lysis syndrome: A single-institution experience
  Bằng: TAKAI, MIHOKO, et al.
  Được phát hành: (2015)
• Analysis of the incidence of tumor lysis syndrome in patients with hematological malignancies treated with rasburicase
  Bằng: Usami, Eiseki, et al.
  Được phát hành: (2017)
• Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents
  Bằng: Cheson, Bruce D., et al.
  Được phát hành: (2017)